Drug · DIN 02557452
AUGTYRO
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since October 17, 2025.
- Drug Identification Number (DIN)
- 02557452
- Company (DIN owner)
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Repotrectinib L01EX28
- Class
- Human
- Record last updated
- November 5, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| REPOTRECTINIB | 160 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 7, 2025: NOC 35313New Drug Submission (NDS)
Other DINs named AUGTYRO
- DIN 02557444 · Cancelled Pre Market